Pharma & Healthcare
Global Budesonide Capsules Market Research Report 2024
- Jan 18, 24
- ID: 3186
- Pages: 81
- Figures: 182
- Views: 20
Budesonide is a first-line anti-inflammatory agent and locally acting glucocorticosteroid indicated for the induction and maintenance of remission of mild to moderate ileocaecal Crohn's disease (capsules) and ulcerative colitis (enemas) as well as for the remission of active microscopic colitis (capsules).
The global Budesonide Capsules market was valued at US$ 902.3 million in 2023 and is anticipated to reach US$ 1646.3 million by 2030, witnessing a CAGR of 9.1% during the forecast period 2024-2030.
North American market for Budesonide Capsules is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Budesonide Capsules is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Budesonide Capsules include Perrigo, Mylan, Tillotts Pharma, Teva, Zydus Pharmaceuticals, Amneal, Mayne Pharma and Sciecure Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Budesonide Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Budesonide Capsules.
Report Scope
The Budesonide Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Budesonide Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Budesonide Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Perrigo
Mylan
Tillotts Pharma
Teva
Zydus Pharmaceuticals
Amneal
Mayne Pharma
Sciecure Pharma
Segment by Type
1mg
2mg
3mg
Segment by Application
Crohn's Disease
Collagenous Colitis
Autoimmune Hepatitis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Budesonide Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Budesonide Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Budesonide Capsules market was valued at US$ 902.3 million in 2023 and is anticipated to reach US$ 1646.3 million by 2030, witnessing a CAGR of 9.1% during the forecast period 2024-2030.
North American market for Budesonide Capsules is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Budesonide Capsules is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Budesonide Capsules include Perrigo, Mylan, Tillotts Pharma, Teva, Zydus Pharmaceuticals, Amneal, Mayne Pharma and Sciecure Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Budesonide Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Budesonide Capsules.
Report Scope
The Budesonide Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Budesonide Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Budesonide Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Perrigo
Mylan
Tillotts Pharma
Teva
Zydus Pharmaceuticals
Amneal
Mayne Pharma
Sciecure Pharma
Segment by Type
1mg
2mg
3mg
Segment by Application
Crohn's Disease
Collagenous Colitis
Autoimmune Hepatitis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Budesonide Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Budesonide Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Budesonide Capsules Market Overview
1.1 Product Overview and Scope of Budesonide Capsules
1.2 Budesonide Capsules Segment by Type
1.2.1 Global Budesonide Capsules Market Value Comparison by Type (2024-2030)
1.2.2 1mg
1.2.3 2mg
1.2.4 3mg
1.3 Budesonide Capsules Segment by Application
1.3.1 Global Budesonide Capsules Market Value by Application: (2024-2030)
1.3.2 Crohn's Disease
1.3.3 Collagenous Colitis
1.3.4 Autoimmune Hepatitis
1.4 Global Budesonide Capsules Market Size Estimates and Forecasts
1.4.1 Global Budesonide Capsules Revenue 2019-2030
1.4.2 Global Budesonide Capsules Sales 2019-2030
1.4.3 Global Budesonide Capsules Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Budesonide Capsules Market Competition by Manufacturers
2.1 Global Budesonide Capsules Sales Market Share by Manufacturers (2019-2024)
2.2 Global Budesonide Capsules Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Budesonide Capsules Average Price by Manufacturers (2019-2024)
2.4 Global Budesonide Capsules Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Budesonide Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Budesonide Capsules, Product Type & Application
2.7 Budesonide Capsules Market Competitive Situation and Trends
2.7.1 Budesonide Capsules Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Budesonide Capsules Players Market Share by Revenue
2.7.3 Global Budesonide Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Budesonide Capsules Retrospective Market Scenario by Region
3.1 Global Budesonide Capsules Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Budesonide Capsules Global Budesonide Capsules Sales by Region: 2019-2030
3.2.1 Global Budesonide Capsules Sales by Region: 2019-2024
3.2.2 Global Budesonide Capsules Sales by Region: 2025-2030
3.3 Global Budesonide Capsules Global Budesonide Capsules Revenue by Region: 2019-2030
3.3.1 Global Budesonide Capsules Revenue by Region: 2019-2024
3.3.2 Global Budesonide Capsules Revenue by Region: 2025-2030
3.4 North America Budesonide Capsules Market Facts & Figures by Country
3.4.1 North America Budesonide Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Budesonide Capsules Sales by Country (2019-2030)
3.4.3 North America Budesonide Capsules Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Budesonide Capsules Market Facts & Figures by Country
3.5.1 Europe Budesonide Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Budesonide Capsules Sales by Country (2019-2030)
3.5.3 Europe Budesonide Capsules Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Budesonide Capsules Market Facts & Figures by Country
3.6.1 Asia Pacific Budesonide Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Budesonide Capsules Sales by Country (2019-2030)
3.6.3 Asia Pacific Budesonide Capsules Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Budesonide Capsules Market Facts & Figures by Country
3.7.1 Latin America Budesonide Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Budesonide Capsules Sales by Country (2019-2030)
3.7.3 Latin America Budesonide Capsules Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Budesonide Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Budesonide Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Budesonide Capsules Sales by Country (2019-2030)
3.8.3 Middle East and Africa Budesonide Capsules Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Budesonide Capsules Sales by Type (2019-2030)
4.1.1 Global Budesonide Capsules Sales by Type (2019-2024)
4.1.2 Global Budesonide Capsules Sales by Type (2025-2030)
4.1.3 Global Budesonide Capsules Sales Market Share by Type (2019-2030)
4.2 Global Budesonide Capsules Revenue by Type (2019-2030)
4.2.1 Global Budesonide Capsules Revenue by Type (2019-2024)
4.2.2 Global Budesonide Capsules Revenue by Type (2025-2030)
4.2.3 Global Budesonide Capsules Revenue Market Share by Type (2019-2030)
4.3 Global Budesonide Capsules Price by Type (2019-2030)
5 Segment by Application
5.1 Global Budesonide Capsules Sales by Application (2019-2030)
5.1.1 Global Budesonide Capsules Sales by Application (2019-2024)
5.1.2 Global Budesonide Capsules Sales by Application (2025-2030)
5.1.3 Global Budesonide Capsules Sales Market Share by Application (2019-2030)
5.2 Global Budesonide Capsules Revenue by Application (2019-2030)
5.2.1 Global Budesonide Capsules Revenue by Application (2019-2024)
5.2.2 Global Budesonide Capsules Revenue by Application (2025-2030)
5.2.3 Global Budesonide Capsules Revenue Market Share by Application (2019-2030)
5.3 Global Budesonide Capsules Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Perrigo
6.1.1 Perrigo Corporation Information
6.1.2 Perrigo Description and Business Overview
6.1.3 Perrigo Budesonide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Perrigo Budesonide Capsules Product Portfolio
6.1.5 Perrigo Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Corporation Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Budesonide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mylan Budesonide Capsules Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Tillotts Pharma
6.3.1 Tillotts Pharma Corporation Information
6.3.2 Tillotts Pharma Description and Business Overview
6.3.3 Tillotts Pharma Budesonide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Tillotts Pharma Budesonide Capsules Product Portfolio
6.3.5 Tillotts Pharma Recent Developments/Updates
6.4 Teva
6.4.1 Teva Corporation Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Budesonide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Budesonide Capsules Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Zydus Pharmaceuticals
6.5.1 Zydus Pharmaceuticals Corporation Information
6.5.2 Zydus Pharmaceuticals Description and Business Overview
6.5.3 Zydus Pharmaceuticals Budesonide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zydus Pharmaceuticals Budesonide Capsules Product Portfolio
6.5.5 Zydus Pharmaceuticals Recent Developments/Updates
6.6 Amneal
6.6.1 Amneal Corporation Information
6.6.2 Amneal Description and Business Overview
6.6.3 Amneal Budesonide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Amneal Budesonide Capsules Product Portfolio
6.6.5 Amneal Recent Developments/Updates
6.7 Mayne Pharma
6.6.1 Mayne Pharma Corporation Information
6.6.2 Mayne Pharma Description and Business Overview
6.6.3 Mayne Pharma Budesonide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mayne Pharma Budesonide Capsules Product Portfolio
6.7.5 Mayne Pharma Recent Developments/Updates
6.8 Sciecure Pharma
6.8.1 Sciecure Pharma Corporation Information
6.8.2 Sciecure Pharma Description and Business Overview
6.8.3 Sciecure Pharma Budesonide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sciecure Pharma Budesonide Capsules Product Portfolio
6.8.5 Sciecure Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Budesonide Capsules Industry Chain Analysis
7.2 Budesonide Capsules Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Budesonide Capsules Production Mode & Process
7.4 Budesonide Capsules Sales and Marketing
7.4.1 Budesonide Capsules Sales Channels
7.4.2 Budesonide Capsules Distributors
7.5 Budesonide Capsules Customers
8 Budesonide Capsules Market Dynamics
8.1 Budesonide Capsules Industry Trends
8.2 Budesonide Capsules Market Drivers
8.3 Budesonide Capsules Market Challenges
8.4 Budesonide Capsules Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Budesonide Capsules
1.2 Budesonide Capsules Segment by Type
1.2.1 Global Budesonide Capsules Market Value Comparison by Type (2024-2030)
1.2.2 1mg
1.2.3 2mg
1.2.4 3mg
1.3 Budesonide Capsules Segment by Application
1.3.1 Global Budesonide Capsules Market Value by Application: (2024-2030)
1.3.2 Crohn's Disease
1.3.3 Collagenous Colitis
1.3.4 Autoimmune Hepatitis
1.4 Global Budesonide Capsules Market Size Estimates and Forecasts
1.4.1 Global Budesonide Capsules Revenue 2019-2030
1.4.2 Global Budesonide Capsules Sales 2019-2030
1.4.3 Global Budesonide Capsules Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Budesonide Capsules Market Competition by Manufacturers
2.1 Global Budesonide Capsules Sales Market Share by Manufacturers (2019-2024)
2.2 Global Budesonide Capsules Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Budesonide Capsules Average Price by Manufacturers (2019-2024)
2.4 Global Budesonide Capsules Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Budesonide Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Budesonide Capsules, Product Type & Application
2.7 Budesonide Capsules Market Competitive Situation and Trends
2.7.1 Budesonide Capsules Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Budesonide Capsules Players Market Share by Revenue
2.7.3 Global Budesonide Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Budesonide Capsules Retrospective Market Scenario by Region
3.1 Global Budesonide Capsules Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Budesonide Capsules Global Budesonide Capsules Sales by Region: 2019-2030
3.2.1 Global Budesonide Capsules Sales by Region: 2019-2024
3.2.2 Global Budesonide Capsules Sales by Region: 2025-2030
3.3 Global Budesonide Capsules Global Budesonide Capsules Revenue by Region: 2019-2030
3.3.1 Global Budesonide Capsules Revenue by Region: 2019-2024
3.3.2 Global Budesonide Capsules Revenue by Region: 2025-2030
3.4 North America Budesonide Capsules Market Facts & Figures by Country
3.4.1 North America Budesonide Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Budesonide Capsules Sales by Country (2019-2030)
3.4.3 North America Budesonide Capsules Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Budesonide Capsules Market Facts & Figures by Country
3.5.1 Europe Budesonide Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Budesonide Capsules Sales by Country (2019-2030)
3.5.3 Europe Budesonide Capsules Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Budesonide Capsules Market Facts & Figures by Country
3.6.1 Asia Pacific Budesonide Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Budesonide Capsules Sales by Country (2019-2030)
3.6.3 Asia Pacific Budesonide Capsules Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Budesonide Capsules Market Facts & Figures by Country
3.7.1 Latin America Budesonide Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Budesonide Capsules Sales by Country (2019-2030)
3.7.3 Latin America Budesonide Capsules Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Budesonide Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Budesonide Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Budesonide Capsules Sales by Country (2019-2030)
3.8.3 Middle East and Africa Budesonide Capsules Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Budesonide Capsules Sales by Type (2019-2030)
4.1.1 Global Budesonide Capsules Sales by Type (2019-2024)
4.1.2 Global Budesonide Capsules Sales by Type (2025-2030)
4.1.3 Global Budesonide Capsules Sales Market Share by Type (2019-2030)
4.2 Global Budesonide Capsules Revenue by Type (2019-2030)
4.2.1 Global Budesonide Capsules Revenue by Type (2019-2024)
4.2.2 Global Budesonide Capsules Revenue by Type (2025-2030)
4.2.3 Global Budesonide Capsules Revenue Market Share by Type (2019-2030)
4.3 Global Budesonide Capsules Price by Type (2019-2030)
5 Segment by Application
5.1 Global Budesonide Capsules Sales by Application (2019-2030)
5.1.1 Global Budesonide Capsules Sales by Application (2019-2024)
5.1.2 Global Budesonide Capsules Sales by Application (2025-2030)
5.1.3 Global Budesonide Capsules Sales Market Share by Application (2019-2030)
5.2 Global Budesonide Capsules Revenue by Application (2019-2030)
5.2.1 Global Budesonide Capsules Revenue by Application (2019-2024)
5.2.2 Global Budesonide Capsules Revenue by Application (2025-2030)
5.2.3 Global Budesonide Capsules Revenue Market Share by Application (2019-2030)
5.3 Global Budesonide Capsules Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Perrigo
6.1.1 Perrigo Corporation Information
6.1.2 Perrigo Description and Business Overview
6.1.3 Perrigo Budesonide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Perrigo Budesonide Capsules Product Portfolio
6.1.5 Perrigo Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Corporation Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Budesonide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mylan Budesonide Capsules Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Tillotts Pharma
6.3.1 Tillotts Pharma Corporation Information
6.3.2 Tillotts Pharma Description and Business Overview
6.3.3 Tillotts Pharma Budesonide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Tillotts Pharma Budesonide Capsules Product Portfolio
6.3.5 Tillotts Pharma Recent Developments/Updates
6.4 Teva
6.4.1 Teva Corporation Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Budesonide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Budesonide Capsules Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Zydus Pharmaceuticals
6.5.1 Zydus Pharmaceuticals Corporation Information
6.5.2 Zydus Pharmaceuticals Description and Business Overview
6.5.3 Zydus Pharmaceuticals Budesonide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zydus Pharmaceuticals Budesonide Capsules Product Portfolio
6.5.5 Zydus Pharmaceuticals Recent Developments/Updates
6.6 Amneal
6.6.1 Amneal Corporation Information
6.6.2 Amneal Description and Business Overview
6.6.3 Amneal Budesonide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Amneal Budesonide Capsules Product Portfolio
6.6.5 Amneal Recent Developments/Updates
6.7 Mayne Pharma
6.6.1 Mayne Pharma Corporation Information
6.6.2 Mayne Pharma Description and Business Overview
6.6.3 Mayne Pharma Budesonide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mayne Pharma Budesonide Capsules Product Portfolio
6.7.5 Mayne Pharma Recent Developments/Updates
6.8 Sciecure Pharma
6.8.1 Sciecure Pharma Corporation Information
6.8.2 Sciecure Pharma Description and Business Overview
6.8.3 Sciecure Pharma Budesonide Capsules Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sciecure Pharma Budesonide Capsules Product Portfolio
6.8.5 Sciecure Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Budesonide Capsules Industry Chain Analysis
7.2 Budesonide Capsules Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Budesonide Capsules Production Mode & Process
7.4 Budesonide Capsules Sales and Marketing
7.4.1 Budesonide Capsules Sales Channels
7.4.2 Budesonide Capsules Distributors
7.5 Budesonide Capsules Customers
8 Budesonide Capsules Market Dynamics
8.1 Budesonide Capsules Industry Trends
8.2 Budesonide Capsules Market Drivers
8.3 Budesonide Capsules Market Challenges
8.4 Budesonide Capsules Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Budesonide Capsules Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Budesonide Capsules Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Budesonide Capsules Market Competitive Situation by Manufacturers in 2023
Table 4. Global Budesonide Capsules Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Budesonide Capsules Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Budesonide Capsules Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Budesonide Capsules Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Budesonide Capsules Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Budesonide Capsules, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Budesonide Capsules, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Budesonide Capsules, Product Type & Application
Table 12. Global Key Manufacturers of Budesonide Capsules, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Budesonide Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Budesonide Capsules as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Budesonide Capsules Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Budesonide Capsules Sales by Region (2019-2024) & (K Units)
Table 18. Global Budesonide Capsules Sales Market Share by Region (2019-2024)
Table 19. Global Budesonide Capsules Sales by Region (2025-2030) & (K Units)
Table 20. Global Budesonide Capsules Sales Market Share by Region (2025-2030)
Table 21. Global Budesonide Capsules Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Budesonide Capsules Revenue Market Share by Region (2019-2024)
Table 23. Global Budesonide Capsules Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Budesonide Capsules Revenue Market Share by Region (2025-2030)
Table 25. North America Budesonide Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Budesonide Capsules Sales by Country (2019-2024) & (K Units)
Table 27. North America Budesonide Capsules Sales by Country (2025-2030) & (K Units)
Table 28. North America Budesonide Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Budesonide Capsules Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Budesonide Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Budesonide Capsules Sales by Country (2019-2024) & (K Units)
Table 32. Europe Budesonide Capsules Sales by Country (2025-2030) & (K Units)
Table 33. Europe Budesonide Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Budesonide Capsules Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Budesonide Capsules Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Budesonide Capsules Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Budesonide Capsules Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Budesonide Capsules Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Budesonide Capsules Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Budesonide Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Budesonide Capsules Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Budesonide Capsules Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Budesonide Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Budesonide Capsules Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Budesonide Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Budesonide Capsules Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Budesonide Capsules Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Budesonide Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Budesonide Capsules Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Budesonide Capsules Sales (K Units) by Type (2019-2024)
Table 51. Global Budesonide Capsules Sales (K Units) by Type (2025-2030)
Table 52. Global Budesonide Capsules Sales Market Share by Type (2019-2024)
Table 53. Global Budesonide Capsules Sales Market Share by Type (2025-2030)
Table 54. Global Budesonide Capsules Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Budesonide Capsules Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Budesonide Capsules Revenue Market Share by Type (2019-2024)
Table 57. Global Budesonide Capsules Revenue Market Share by Type (2025-2030)
Table 58. Global Budesonide Capsules Price (USD/Unit) by Type (2019-2024)
Table 59. Global Budesonide Capsules Price (USD/Unit) by Type (2025-2030)
Table 60. Global Budesonide Capsules Sales (K Units) by Application (2019-2024)
Table 61. Global Budesonide Capsules Sales (K Units) by Application (2025-2030)
Table 62. Global Budesonide Capsules Sales Market Share by Application (2019-2024)
Table 63. Global Budesonide Capsules Sales Market Share by Application (2025-2030)
Table 64. Global Budesonide Capsules Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Budesonide Capsules Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Budesonide Capsules Revenue Market Share by Application (2019-2024)
Table 67. Global Budesonide Capsules Revenue Market Share by Application (2025-2030)
Table 68. Global Budesonide Capsules Price (USD/Unit) by Application (2019-2024)
Table 69. Global Budesonide Capsules Price (USD/Unit) by Application (2025-2030)
Table 70. Perrigo Corporation Information
Table 71. Perrigo Description and Business Overview
Table 72. Perrigo Budesonide Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Perrigo Budesonide Capsules Product
Table 74. Perrigo Recent Developments/Updates
Table 75. Mylan Corporation Information
Table 76. Mylan Description and Business Overview
Table 77. Mylan Budesonide Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Mylan Budesonide Capsules Product
Table 79. Mylan Recent Developments/Updates
Table 80. Tillotts Pharma Corporation Information
Table 81. Tillotts Pharma Description and Business Overview
Table 82. Tillotts Pharma Budesonide Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Tillotts Pharma Budesonide Capsules Product
Table 84. Tillotts Pharma Recent Developments/Updates
Table 85. Teva Corporation Information
Table 86. Teva Description and Business Overview
Table 87. Teva Budesonide Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Teva Budesonide Capsules Product
Table 89. Teva Recent Developments/Updates
Table 90. Zydus Pharmaceuticals Corporation Information
Table 91. Zydus Pharmaceuticals Description and Business Overview
Table 92. Zydus Pharmaceuticals Budesonide Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Zydus Pharmaceuticals Budesonide Capsules Product
Table 94. Zydus Pharmaceuticals Recent Developments/Updates
Table 95. Amneal Corporation Information
Table 96. Amneal Description and Business Overview
Table 97. Amneal Budesonide Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Amneal Budesonide Capsules Product
Table 99. Amneal Recent Developments/Updates
Table 100. Mayne Pharma Corporation Information
Table 101. Mayne Pharma Description and Business Overview
Table 102. Mayne Pharma Budesonide Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Mayne Pharma Budesonide Capsules Product
Table 104. Mayne Pharma Recent Developments/Updates
Table 105. Sciecure Pharma Corporation Information
Table 106. Sciecure Pharma Description and Business Overview
Table 107. Sciecure Pharma Budesonide Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Sciecure Pharma Budesonide Capsules Product
Table 109. Sciecure Pharma Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Budesonide Capsules Distributors List
Table 113. Budesonide Capsules Customers List
Table 114. Budesonide Capsules Market Trends
Table 115. Budesonide Capsules Market Drivers
Table 116. Budesonide Capsules Market Challenges
Table 117. Budesonide Capsules Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Budesonide Capsules
Figure 2. Global Budesonide Capsules Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Budesonide Capsules Market Share by Type in 2023 & 2030
Figure 4. 1mg Product Picture
Figure 5. 2mg Product Picture
Figure 6. 3mg Product Picture
Figure 7. Global Budesonide Capsules Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Budesonide Capsules Market Share by Application in 2023 & 2030
Figure 9. Crohn's Disease
Figure 10. Collagenous Colitis
Figure 11. Autoimmune Hepatitis
Figure 12. Global Budesonide Capsules Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Budesonide Capsules Market Size (2019-2030) & (US$ Million)
Figure 14. Global Budesonide Capsules Sales (2019-2030) & (K Units)
Figure 15. Global Budesonide Capsules Average Price (USD/Unit) & (2019-2030)
Figure 16. Budesonide Capsules Report Years Considered
Figure 17. Budesonide Capsules Sales Share by Manufacturers in 2023
Figure 18. Global Budesonide Capsules Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Budesonide Capsules Players: Market Share by Revenue in 2023
Figure 20. Budesonide Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Budesonide Capsules Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Budesonide Capsules Sales Market Share by Country (2019-2030)
Figure 23. North America Budesonide Capsules Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Budesonide Capsules Sales Market Share by Country (2019-2030)
Figure 27. Europe Budesonide Capsules Revenue Market Share by Country (2019-2030)
Figure 28. Germany Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Budesonide Capsules Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Budesonide Capsules Revenue Market Share by Region (2019-2030)
Figure 35. China Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Budesonide Capsules Sales Market Share by Country (2019-2030)
Figure 46. Latin America Budesonide Capsules Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Budesonide Capsules Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Budesonide Capsules Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Budesonide Capsules by Type (2019-2030)
Figure 56. Global Revenue Market Share of Budesonide Capsules by Type (2019-2030)
Figure 57. Global Budesonide Capsules Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Budesonide Capsules by Application (2019-2030)
Figure 59. Global Revenue Market Share of Budesonide Capsules by Application (2019-2030)
Figure 60. Global Budesonide Capsules Price (USD/Unit) by Application (2019-2030)
Figure 61. Budesonide Capsules Value Chain
Figure 62. Budesonide Capsules Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Budesonide Capsules Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Budesonide Capsules Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Budesonide Capsules Market Competitive Situation by Manufacturers in 2023
Table 4. Global Budesonide Capsules Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Budesonide Capsules Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Budesonide Capsules Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Budesonide Capsules Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Budesonide Capsules Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Budesonide Capsules, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Budesonide Capsules, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Budesonide Capsules, Product Type & Application
Table 12. Global Key Manufacturers of Budesonide Capsules, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Budesonide Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Budesonide Capsules as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Budesonide Capsules Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Budesonide Capsules Sales by Region (2019-2024) & (K Units)
Table 18. Global Budesonide Capsules Sales Market Share by Region (2019-2024)
Table 19. Global Budesonide Capsules Sales by Region (2025-2030) & (K Units)
Table 20. Global Budesonide Capsules Sales Market Share by Region (2025-2030)
Table 21. Global Budesonide Capsules Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Budesonide Capsules Revenue Market Share by Region (2019-2024)
Table 23. Global Budesonide Capsules Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Budesonide Capsules Revenue Market Share by Region (2025-2030)
Table 25. North America Budesonide Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Budesonide Capsules Sales by Country (2019-2024) & (K Units)
Table 27. North America Budesonide Capsules Sales by Country (2025-2030) & (K Units)
Table 28. North America Budesonide Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Budesonide Capsules Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Budesonide Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Budesonide Capsules Sales by Country (2019-2024) & (K Units)
Table 32. Europe Budesonide Capsules Sales by Country (2025-2030) & (K Units)
Table 33. Europe Budesonide Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Budesonide Capsules Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Budesonide Capsules Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Budesonide Capsules Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Budesonide Capsules Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Budesonide Capsules Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Budesonide Capsules Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Budesonide Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Budesonide Capsules Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Budesonide Capsules Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Budesonide Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Budesonide Capsules Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Budesonide Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Budesonide Capsules Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Budesonide Capsules Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Budesonide Capsules Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Budesonide Capsules Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Budesonide Capsules Sales (K Units) by Type (2019-2024)
Table 51. Global Budesonide Capsules Sales (K Units) by Type (2025-2030)
Table 52. Global Budesonide Capsules Sales Market Share by Type (2019-2024)
Table 53. Global Budesonide Capsules Sales Market Share by Type (2025-2030)
Table 54. Global Budesonide Capsules Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Budesonide Capsules Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Budesonide Capsules Revenue Market Share by Type (2019-2024)
Table 57. Global Budesonide Capsules Revenue Market Share by Type (2025-2030)
Table 58. Global Budesonide Capsules Price (USD/Unit) by Type (2019-2024)
Table 59. Global Budesonide Capsules Price (USD/Unit) by Type (2025-2030)
Table 60. Global Budesonide Capsules Sales (K Units) by Application (2019-2024)
Table 61. Global Budesonide Capsules Sales (K Units) by Application (2025-2030)
Table 62. Global Budesonide Capsules Sales Market Share by Application (2019-2024)
Table 63. Global Budesonide Capsules Sales Market Share by Application (2025-2030)
Table 64. Global Budesonide Capsules Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Budesonide Capsules Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Budesonide Capsules Revenue Market Share by Application (2019-2024)
Table 67. Global Budesonide Capsules Revenue Market Share by Application (2025-2030)
Table 68. Global Budesonide Capsules Price (USD/Unit) by Application (2019-2024)
Table 69. Global Budesonide Capsules Price (USD/Unit) by Application (2025-2030)
Table 70. Perrigo Corporation Information
Table 71. Perrigo Description and Business Overview
Table 72. Perrigo Budesonide Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Perrigo Budesonide Capsules Product
Table 74. Perrigo Recent Developments/Updates
Table 75. Mylan Corporation Information
Table 76. Mylan Description and Business Overview
Table 77. Mylan Budesonide Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Mylan Budesonide Capsules Product
Table 79. Mylan Recent Developments/Updates
Table 80. Tillotts Pharma Corporation Information
Table 81. Tillotts Pharma Description and Business Overview
Table 82. Tillotts Pharma Budesonide Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Tillotts Pharma Budesonide Capsules Product
Table 84. Tillotts Pharma Recent Developments/Updates
Table 85. Teva Corporation Information
Table 86. Teva Description and Business Overview
Table 87. Teva Budesonide Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Teva Budesonide Capsules Product
Table 89. Teva Recent Developments/Updates
Table 90. Zydus Pharmaceuticals Corporation Information
Table 91. Zydus Pharmaceuticals Description and Business Overview
Table 92. Zydus Pharmaceuticals Budesonide Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Zydus Pharmaceuticals Budesonide Capsules Product
Table 94. Zydus Pharmaceuticals Recent Developments/Updates
Table 95. Amneal Corporation Information
Table 96. Amneal Description and Business Overview
Table 97. Amneal Budesonide Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Amneal Budesonide Capsules Product
Table 99. Amneal Recent Developments/Updates
Table 100. Mayne Pharma Corporation Information
Table 101. Mayne Pharma Description and Business Overview
Table 102. Mayne Pharma Budesonide Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Mayne Pharma Budesonide Capsules Product
Table 104. Mayne Pharma Recent Developments/Updates
Table 105. Sciecure Pharma Corporation Information
Table 106. Sciecure Pharma Description and Business Overview
Table 107. Sciecure Pharma Budesonide Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Sciecure Pharma Budesonide Capsules Product
Table 109. Sciecure Pharma Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Budesonide Capsules Distributors List
Table 113. Budesonide Capsules Customers List
Table 114. Budesonide Capsules Market Trends
Table 115. Budesonide Capsules Market Drivers
Table 116. Budesonide Capsules Market Challenges
Table 117. Budesonide Capsules Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Budesonide Capsules
Figure 2. Global Budesonide Capsules Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Budesonide Capsules Market Share by Type in 2023 & 2030
Figure 4. 1mg Product Picture
Figure 5. 2mg Product Picture
Figure 6. 3mg Product Picture
Figure 7. Global Budesonide Capsules Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Budesonide Capsules Market Share by Application in 2023 & 2030
Figure 9. Crohn's Disease
Figure 10. Collagenous Colitis
Figure 11. Autoimmune Hepatitis
Figure 12. Global Budesonide Capsules Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Budesonide Capsules Market Size (2019-2030) & (US$ Million)
Figure 14. Global Budesonide Capsules Sales (2019-2030) & (K Units)
Figure 15. Global Budesonide Capsules Average Price (USD/Unit) & (2019-2030)
Figure 16. Budesonide Capsules Report Years Considered
Figure 17. Budesonide Capsules Sales Share by Manufacturers in 2023
Figure 18. Global Budesonide Capsules Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Budesonide Capsules Players: Market Share by Revenue in 2023
Figure 20. Budesonide Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Budesonide Capsules Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Budesonide Capsules Sales Market Share by Country (2019-2030)
Figure 23. North America Budesonide Capsules Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Budesonide Capsules Sales Market Share by Country (2019-2030)
Figure 27. Europe Budesonide Capsules Revenue Market Share by Country (2019-2030)
Figure 28. Germany Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Budesonide Capsules Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Budesonide Capsules Revenue Market Share by Region (2019-2030)
Figure 35. China Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Budesonide Capsules Sales Market Share by Country (2019-2030)
Figure 46. Latin America Budesonide Capsules Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Budesonide Capsules Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Budesonide Capsules Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Budesonide Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Budesonide Capsules by Type (2019-2030)
Figure 56. Global Revenue Market Share of Budesonide Capsules by Type (2019-2030)
Figure 57. Global Budesonide Capsules Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Budesonide Capsules by Application (2019-2030)
Figure 59. Global Revenue Market Share of Budesonide Capsules by Application (2019-2030)
Figure 60. Global Budesonide Capsules Price (USD/Unit) by Application (2019-2030)
Figure 61. Budesonide Capsules Value Chain
Figure 62. Budesonide Capsules Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232